An article in Clinical Gastroenterology and Hepatology has begun an important step towards developing global guidelines for eosinophilic diseases below the oesophagus.

These conditions have been covered under the umbrella term EGIDs (Eosinophilic Gastro-Intestinal Diseases) for many years.

This has been further defined by the terms EoE (eosinophilic oesophagitis), EG (eosinophilic gastritis), EC (eosinophilic colitis) EGE (eosinophilic gastroenteritis), with new additions such as EoD (Eosinophilic duodenitis) appearing recently.

EoE has become the most clearly-defined EGID, with both guidelines and treatments. Improvements in EoE's definition also demonstrate how far behind the lesser-recognised EGIDs are in comparison.

There's an urgent need for international consensus within research in EG, EC, EGE and EoD. This is vital to further global understanding of these complex conditions and how to treat them.

New EGID nomenclature

Agreeing on terminology will strengthen the evidence provided by the ever-increasing volume of EGID research being produced across the world. EGIDs are still relatively newly-recognised diseases, and international consensus on nomenclature will lead to standardisation of care through much-needed international guidelines.

As a member of CEGIR EOS Network was proud to represent the patient's voice in this important publication, which has brought together 91 world-leading experts in this field.

Article

International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature.

Project conception, coordination, data collection/analysis, data interpretation, manuscript drafting, critical revision of the manuscript and final approval by Evan S. Dellon, Nirmala Gonsalves, Glenn T. Furuta and Seema S. Aceves.

Read the article here

---

Keep updated - Register with us